I think the provisions contained in the TPP agreement provide a mechanism to share information. They provide a commitment to science-based regulations. They provide more predictability and collaboration as to which data is shared back and forth. The question is whether it addresses all of our market-access issues. It probably doesn't but it definitely provides us with a platform for discussion and with a platform to proactively address some of the issues that we are talking about in terms of MRLs or LLPs in canola. Particularly beneficial is that right now there are individual discussions within every one of your exporting markets, whereby we have access to 11 or 12 members of the TPP through one platform. So it's more that platform for dialogue. There's also a working group on biotech products and STS that's going to be created, so it's really those mechanisms that are in the agreement that provide us with the opportunity to address some of the issues that we're facing at the end of the day.
On April 19th, 2016. See this statement in context.